Respiratory Trials·org

Pulmonary embolism · Ruling out pulmonary embolism

PEGeD management cohort

Diagnosis of Pulmonary Embolism with d-Dimer Adjusted to Clinical Probability

PEGeD trial design and results
Design Prospective management study
Treatment D-dimer threshold adjusted to clinical pretest probability: <1000 ng/mL if low, <500 ng/mL if moderate
Control Conventional fixed 500 ng/mL threshold
Population 2017 patients with suspected pulmonary embolism, 7.4% of whom had PE on initial testing
Follow-up 3 months
Primary endpoint Venous thromboembolism during 3-month follow-up in patients in whom PE was ruled out without imaging
Result Of 1325 patients with a low clinical pretest probability and D-dimer below 1000 ng/mL, or moderate probability and D-dimer below 500 ng/mL, none had venous thromboembolism during follow-up.
Secondary endpoints Proportion of patients avoiding CT pulmonary angiography

A combination of a low C-PTP and a d-dimer level of less than 1000 ng per milliliter identified a group of patients at low risk for pulmonary embolism during follow-up.

The trial authors, in the published abstract

How it has aged

One of three concordant strategies — with YEARS and ADJUST-PE — that all do the same thing: raise the D-dimer threshold when clinical probability is low, and scan fewer people. Which algorithm a department adopts matters less than adopting one.

Publications

Diagnosis of Pulmonary Embolism with d-Dimer Adjusted to Clinical Probability

Kearon C, de Wit K, Parpia S, et al. Diagnosis of Pulmonary Embolism with d-Dimer Adjusted to Clinical Probability. N Engl J Med 2019 Nov 28;381(22):2125-2134.

  • No venous thromboembolism during follow-up in the 1325 patients ruled out by the adjusted threshold
  • Substantially fewer CT pulmonary angiograms than a fixed 500 ng/mL cutoff